Sanofi sells Japan­ese man­u­fac­tur­ing site to CD­MO but main­tains sup­ply agree­ment

Sanofi is sell­ing off a piece of its man­u­fac­tur­ing op­er­a­tions in Japan to CD­MO Adra­gos Phar­ma, al­though will con­tin­ue to have its prod­ucts man­u­fac­tured at the site through a new sup­ply agree­ment.

Ger­man CD­MO Adra­gos has ac­quired Sanofi’s phar­ma­ceu­ti­cal man­u­fac­tur­ing site in the city of Kawa­g­oe, Japan, north­west of Tokyo. Un­der the deal, Adra­gos will en­ter in­to a “long-term sup­ply agree­ment” with Sanofi in the Japan­ese mar­ket as well as serv­ing cus­tomers from Eu­rope, North Amer­i­ca, and Japan from the site. De­tails of the agree­ment were not dis­closed.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER